A Dual Approach to Combat Alzheimer’s
The rosemary compound for Alzheimer’s tackles more than just a one dementia-like disease. Unlike current therapies that only target single proteins like amyloid-beta, diAcCA reduces inflammation and synaptic loss. This multi-faceted approach could enhance the efficacy of existing treatments, such as amyloid antibodies, by reducing inflammatory side effects like brain swelling. Dr. Lipton highlights diAcCA’s potential to work in tandem with other drugs. “It could make existing treatments work better by limiting their side effects” said Dr. Lipton.